Alyeska Investment Group’s NEVRO CORP. NVRO Stock Holding History

Alyeska Investment Group’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-275,000	Closed	-$22.3M	–	685
2021 Q4	$22.3M	Sell	275,000 -25,000	-8%	-$2.51M	0.26%	122
2021 Q3	$34.9M	Buy	+300,000	New	+$39.3M	0.43%	72
2021 Q2	–	Sell	-3,655	Closed	-$510K	–	868
2021 Q1	$510K	Sell	3,655 -8,100	-69%	-$1.32M	0.01%	666
2020 Q4	$2.04M	Buy	+11,755	New	+$1.9M	0.03%	371
2020 Q3	–	Sell	-118,491	Closed	-$14.2M	–	606
2020 Q2	$14.2M	Buy	+118,491	New	+$14.1M	0.21%	153
2018 Q3	–	Sell	-269,816	Closed	-$21.5M	–	527
2018 Q2	$21.5M	Buy	+269,816	New	+$22.4M	0.19%	144
2018 Q1	–	Sell	-37,400	Closed	-$2.58M	–	526
2017 Q4	$2.58M	Buy	+37,400	New	+$2.99M	0.02%	314
2016 Q4	–	Sell	-8,808	Closed	-$919K	–	561
2016 Q3	$919K	Sell	8,808 -32,559	-79%	-$2.94M	0.01%	419
2016 Q2	$3.05M	Buy	41,367 +6,750	+19%	+$458K	0.03%	341
2016 Q1	$1.95M	Buy	+34,617	New	+$2.04M	0.02%	332

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Alyeska Investment Group's NVRO Position: Q1 2022 in Review

Alyeska Investment Group sold out of NEVRO CORP. (NVRO) in Q1 2022, closing a stake of 275,000 shares — an estimated $22.3M sold.

Alyeska Investment Group first reported a position in NVRO in Q1 2016 and held it in 10 quarters. The position peaked at $34.9M in Q3 2021. 195 funds tracked by Wall St. Rank hold NVRO as of Q1 2022.

Alyeska Investment Group reported no remaining NEVRO CORP. position as of Q1 2022 after selling out during the quarter.
Alyeska Investment Group sold 275,000 NEVRO CORP. shares in Q1 2022, an estimated $22.3M.
Alyeska Investment Group first reported a position in NEVRO CORP. in Q1 2016 and held it in 10 quarters.
Alyeska Investment Group's NEVRO CORP. position peaked at $34.9M in Q3 2021.
195 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.